stockrowANI Pharmaceuticals, Inc. (ANIP) vs Phibro Animal Health Corporation (PAHC)
- ANI Pharmaceuticals, Inc. ANIP 68.56 −1.52%
- Phibro Animal Health Corporation PAHC 34.04 −3.84%
ANI Pharmaceuticals, Inc. and Phibro Animal Health Corporation are both Drug Manufacturers Specialty & Generic companies. ANI Pharmaceuticals, Inc. is the larger, with a market value of $1.6B against $1.4B — 1.1× the size. ANI Pharmaceuticals, Inc. trades at the lower P/E: 13.3× against 14.0×. ANI Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 25.9% against 10.1%. ANI Pharmaceuticals, Inc. has the higher net margin (11.2% vs 6.67%) and the higher return on invested capital (46.4% vs 11.3%). Across the 22 metrics below, ANI Pharmaceuticals, Inc. leads on 17 and Phibro Animal Health Corporation on 5.
Valuation
Profitability
| Metric | ANIP | PAHC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 61.06% | 33.83% | 53.51% |
| Operating margin | 15.99% | 12.51% | 0.00% |
| Net margin | 11.22% | 6.67% | (2.45%) |
| Free cash flow margin | 19.72% | 1.41% | 0.00% |
| Return on equity | 20.45% | 28.17% | (0.80%) |
| Return on assets | 7.85% | 7.08% | (1.67%) |
| Return on invested capital | 46.43% | 11.27% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack